Does NMN cause or accelerate cancer?
This is a fair question that deserves nuance. NAD+ is required by all dividing cells, including cancer cells, so theoretical concerns exist. Published trial data shows no increased cancer incidence at studied doses over 10-12 weeks. However: anyone with active cancer or a history of NAD+-dependent cancers (some lymphomas, sarcomas) should pause NMN until in remission and consult an oncologist. Daily NMN at 250 to 500mg in cancer-free adults is not associated with cancer in available evidence. Larger long-term safety studies are still emerging.
Why this matters for Malaysian buyers
NMN buying decisions in Malaysia involve a stack of considerations that don't always map to advice from US- or EU-focused sources: NPRA notification status, JAKIM halal certification (or its absence), tropical-climate storage realities, mall pharmacy versus Shopee Malaysia tradeoffs, and how local medical practitioners typically respond to questions about supplements outside their training. We answer questions like "Does NMN cause or accelerate cancer?" through the lens of Malaysian buyer realities - not generic global guidance.
Verify the source
This individual Q&A is a supporting note, not an indexable authority article. Health-relevant claims should be refreshed against the linked primary or official sources before they are used for buying or medical discussions.
- Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects (2022)
- Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women (2022)
- The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023)
- National Pharmaceutical Regulatory Agency (NPRA) Malaysia - Quest3+ MAL Number Registry (2026)
- MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults (2023)
Adjacent tools
Need to act on this answer? Try the halal checker, the cost calculator, the stack builder, or the brand selector quiz - each tool turns advice into actionable output for your specific situation.
More questions? Browse the full Q&A library (10 categories) · See our main FAQ · Browse NMN brand comparisons · NR brand comparisons.